Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Vincristine

Ayoola O. Awosika  1 , Jameshia Below  2 , Joe M. Das  3
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Vincristine

Ayoola O. Awosika et al.
Free Books & Documents

Excerpt

Vincristine is a chemotherapy medication used to treat various types of cancer, including leukemia, lymphoma, neuroblastoma, and Wilms tumor. Vincristine belongs to the category of vinca alkaloids, a class of drugs that function by impeding the proper division of cancer cells. This drug inhibits cell growth by disrupting mitosis by interfering with microtubule polymerization. Vincristine is also utilized off-label for central nervous system (CNS) tumors, Ewing sarcoma, gestational trophoblastic tumors, multiple myeloma, ovarian cancer, primary CNS lymphoma, small cell lung cancer, and advanced thymoma in adult patients. This therapeutic review evaluates vincristine's role in diverse cancer treatment protocols, including combination therapies. This activity identifies common and rare adverse effects of vincristine while developing strategies for managing and minimizing toxicities associated with the drug. This activity considers long-term outcomes of patients, encompassing disease remission, survival rates, and quality of life. The aim is to equip healthcare professionals with the requisite knowledge and skills for ensuring the safe and effective care of patients receiving vincristine, ultimately contributing to enhanced patient outcomes within the field of oncology practice.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Ayoola Awosika declares no relevant financial relationships with ineligible companies.

Disclosure: Jameshia Below declares no relevant financial relationships with ineligible companies.

Disclosure: Joe Das declares no relevant financial relationships with ineligible companies.

References

    1. Waterhouse DN, Madden TD, Cullis PR, Bally MB, Mayer LD, Webb MS. Preparation, characterization, and biological analysis of liposomal formulations of vincristine. Methods Enzymol. 2005;391:40-57. - PubMed
    1. Mohammadgholi A, Rabbani-Chadegani A, Fallah S. Mechanism of the interaction of plant alkaloid vincristine with DNA and chromatin: spectroscopic study. DNA Cell Biol. 2013 May;32(5):228-35. - PMC - PubMed
    1. Schiller GJ, Damon LE, Coutre SE, Hsu P, Bhat G, Douer D. High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial. J Adolesc Young Adult Oncol. 2018 Oct;7(5):546-552. - PubMed
    1. Zhou X, Xu Z, Li A, Zhang Z, Xu S. Double-sides sticking mechanism of vinblastine interacting with α,β-tubulin to get activity against cancer cells. J Biomol Struct Dyn. 2019 Sep;37(15):4080-4091. - PubMed
    1. Pernot B, Gyan E, Maillot F, Hodges P, Ertault M, Ferreira-Maldent N. Lymphomas diagnosed in an internal medicine department compared to lymphomas diagnosed in other departments: Clinical and outcome differences. Medicine (Baltimore) 2018 Nov;97(47):e13228. - PMC - PubMed

Publication types

LinkOut - more resources